JOSE POLANCO: Open Payments
NPI 1043854961 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 59 payments from 16 companies in 2025. Trend: 2023 $1,152 · 2024 $1,370 · 2025 $1,756
Food & beverage: $1,756
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $667 |
| AstraZeneca Pharmaceuticals LP | 3 | $255 |
| Novo Nordisk Inc | 6 | $191 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $174 |
| Ardelyx, Inc. | 6 | $114 |
| Dexcom, Inc. | 5 | $101 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Abbott Laboratories | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Exact Sciences Corporation | 1 | $30 |
Products named: REZDIFFRA, XIFAXAN, Wegovy, BREZTRI, AIRSUPRA, IBSRELA, Dexcom G6 Transmitter, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
